Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7REA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,994
Award facts
- Contract value 100% obligated
- $15,994.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 21, 2026, for BEYFORTUS 50 MG/0.5 ML syringes with a ceiling value of $15,994.35, firm fixed price.
Place of performance is Conshohocken, PA. Ultimate completion date is April 22, 2026. The order is issued without a set-aside under DLA's Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract, which supports worldwide military healthcare supply across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F7REA?
SPE2DR26F7REA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 21, 2026.
How much is contract SPE2DR26F7REA worth?
The government has obligated $15,994 on SPE2DR26F7REA.
Is contract SPE2DR26F7REA an order under another contract?
Yes. SPE2DR26F7REA is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7REA competed?
The extent of competition for SPE2DR26F7REA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award